14.2 Innate (Non-Specific) Immunity & Inflammation

Innate (Non-Specific) Immunity & Inflammation

The human immune system is organized into two interlocking divisions: innate (non-specific) immunity and adaptive (specific) immunity. Innate immunity represents the evolutionary ancient, operational baseline of host defense. It is present at birth (congenital), responds immediately upon microbial challenge, and deploys identical defensive mechanisms regardless of whether a pathogen has been encountered previously. Unlike adaptive immunity, innate immunity lacks exquisite epitope specificity and does not generate immunological memory cells.

Innate defenses are grouped into two concentric functional barriers:

1. First Line of Defense: External surface barriers—the skin and mucous membranes, including their physical structures and chemical secretions.
2. Second Line of Defense: Internal cellular and chemical defenses—phagocytic leukocytes, natural killer cells, antimicrobial proteins (interferons and the complement cascade), the acute inflammatory response, and systemic fever.

---

The First Line of Defense: Surface Barriers

Surface barriers form the interface between the sterile internal tissues of the body and the external environment. They utilize both mechanical and biochemical strategies to repel, entrap, and destroy pathogens before they breach epithelial boundaries.

Mechanical and Physical Epithelial Barriers

• Intact Skin (Epidermis): The epidermis consists of heavily keratinized, stratified squamous epithelium. Keratin is a tough, fibrous insoluble protein highly resistant to bacterial enzymes, weak acids, and mechanical shearing. Furthermore, epidermal cells continuously desquamate (slough off), physically discarding adhering microorganisms.
• Mucous Membranes (Mucosae): Line all body cavities that open to the external environment, including the digestive, respiratory, urinary, and reproductive tracts. Goblet cells and submucosal glands secrete mucus, a viscous glycoprotein gel that entraps inhaled or ingested particulate matter, bacteria, and fungal spores.
• Respiratory Mucociliary Escalator: Pseudostratified ciliated columnar epithelial cells lining the trachea and bronchi bear coordinated apical cilia. These cilia beat rhythmically in a cephalad direction at 10 to 20 cycles per second, sweeping trapped mucus and particulates out of the lower respiratory tract toward the pharynx, where it is swallowed and sterilized in the stomach or expectorated.
• Physical Washing Actions: Mechanical fluid flow washes epithelial surfaces continuously. Tears secreted by the lacrimal apparatus wash the conjunctiva; saliva bathes the oral cavity; urine flow flushes the urethra; and rhythmic peristaltic contractions sweep intestinal contents downward, preventing retrograde microbial colonization.

Chemical Defenses of the Epithelium

Surface tissues secrete a diverse array of biochemical inhibitors that destroy microorganisms directly or create inhospitable microenvironments:

• Acid Mantle of the Skin: Secretions from sweat (sudoriferous) glands and sebaceous glands produce a thin surface film called the acid mantle. Sebum contains antibacterial unsaturated fatty acids, while sweat contains lactic acid, maintaining a cutaneous surface pH of 4.5 to 5.5 that retards bacterial growth.
• Gastric Juice: Parietal cells of the gastric mucosa secrete concentrated hydrochloric acid (HCl), producing a gastric luminal pH of 1.5 to 3.5. This intense acidity destroys virtually all swallowed vegetative bacteria, viruses, and microbial toxins, while activating pepsin to digest microbial proteins.
• Lysozyme: A bactericidal enzyme present in high concentrations in tears, saliva, nasal mucus, and perspiration. Lysozyme catalyzes the hydrolysis of beta-1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan, selectively lysing Gram-positive bacterial cell walls.
• Vaginal Secretions: In adult females, glycogen secreted by vaginal epithelial cells is fermented into lactic acid by resident Lactobacillus species. This maintains an acidic vaginal pH (3.8 to 4.5) that inhibits the overgrowth of pathogenic bacteria and Candida albicans.
• Defensins: Cysteine-rich antimicrobial peptides secreted by epithelial cells and neutrophil granules. Defensins insert directly into bacterial and fungal cell membranes, forming disruptive pores that lead to microbial lysis.

---

The Second Line of Defense: Cellular Protectors

When pathogens penetrate epithelial surface barriers through lacerations, burns, or mucosal ulcerations, internal cellular defenses engage immediately.

Phagocytic Leukocytes: Neutrophils and Macrophages

Phagocytes are specialized cells that engulf, digest, and neutralize particulate matter, microbial invaders, and cellular debris.

• Neutrophils (Polymorphonuclear Leukocytes / PMNs): The most abundant circulating leukocytes (accounting for 50% to 70% of total white blood cells). Neutrophils act as rapid first responders to acute bacterial infection. They migrate swiftly into damaged tissues, phagocytize bacteria, discharge toxic granules, and release neutrophil extracellular traps (NETs)—webs of extracellular chromatin and antimicrobial proteins that ensnare microbes. Neutrophils are short-lived cells that die fighting, and their accumulated corpses, liquefied necrotic tissue, and fluid form pus (purulent exudate).
• Macrophages: The heavy artillery of cellular innate defense, derived from circulating blood monocytes that leave the vasculature and enlarge five-fold in tissues. Macrophages are long-lived, voracious phagocytes capable of engulfing up to 100 bacteria before dying. They are divided into two operational populations:
  • Free (Wandering) Macrophages: Actively crawl through interstitial spaces seeking foreign targets (e.g., alveolar macrophages / dust cells in the pulmonary alveoli, peritoneal macrophages).
  • Fixed (Resident) Macrophages: Permanently stationed within specific organs to filter regional fluids: Kupffer cells (stellate macrophages) in liver sinusoids, microglia in the central nervous system, osteoclasts in bone, splenic macrophages in the red pulp, and histiocytes in connective tissue.

The Five Sequential Steps of Phagocytosis

Phagocytosis is an active, receptor-mediated biological process executing five sequential stages:

1. Chemotaxis (Locomotion toward chemical gradient)
        │
        ▼
2. Adherence (Binding to microbial surface; enhanced by Opsonization)
        │
        ▼
3. Ingestion (Pseudopods envelop microbe to form Phagosome)
        │
        ▼
4. Phagolysosome Formation & Digestion (Lysosomal fusion + Respiratory Burst)
        │
        ▼
5. Exocytosis (Discharge of residual indigestible waste)

1. Chemotaxis: The phagocyte undergoes directional, amoeboid locomotion toward the injury site, guided along a positive chemical concentration gradient of chemotactic factors (chemokines, complement fragments C5a and C3a, leukotrienes, and bacterial formyl peptides).
2. Adherence (Attachment): The phagocyte binds to the target pathogen. Phagocyte pattern recognition receptors (PRRs, such as Toll-like receptors) recognize repeating microbial molecular signatures called pathogen-associated molecular patterns (PAMPs), such as bacterial lipopolysaccharide (LPS) or peptidoglycan. Microbes with slippery polysaccharide capsules (e.g., Streptococcus pneumoniae) resist adherence. Adherence is dramatically accelerated by opsonization ("to make tasty"), wherein host proteins called opsonins—predominantly complement fragment C3b and immunoglobulin IgG antibodies—coat the microbial surface, providing high-affinity binding handles for phagocyte receptors.
3. Ingestion: The phagocyte projects cytoplasmic extensions called pseudopods around the pathogen. The pseudopods meet and fuse, enclosing the microbe within a membrane-bound intracellular vesicle termed a phagosome (phagocytic vesicle).
4. Phagolysosome Formation and Digestion: The phagosome travels inward and fuses with one or more primary lysosomes to create a phagolysosome. Lysosomes release a potent cocktail of acid hydrolases, lysozyme, and defensins into the vesicle lumen, where an acidic pH (4.0-5.0) activates digestive enzymes. Simultaneously, the phagocyte activates the respiratory burst (oxidative burst), via NADPH oxidase, generating lethal reactive oxygen species (ROS): superoxide radicals ($\text{O}_2^{\bullet-}$), hydrogen peroxide ($\text{H}_2\text{O}_2$), and hypochlorite ions ($\text{OCl}^-$, the active ingredient in bleach). Nitric oxide (NO) is also synthesized to produce reactive nitrogen intermediates, completely sterilizing and fragmenting the pathogen.
5. Exocytosis: After enzymatic degradation, the vesicle—now termed a residual body—migrates to the cell perimeter and fuses with the plasma membrane, expelling indigestible waste materials into the extracellular space. In macrophages and dendritic cells, immunogenic peptide fragments are salvaged and loaded onto Class II MHC molecules for antigen presentation.

Natural Killer (NK) Cells

Natural Killer (NK) cells represent a unique subset of large granular lymphocytes that function as cytotoxic effector cells of the innate immune system. Unlike T-lymphocytes, NK cells do not express clonally distributed antigen receptors and do not require prior sensitization or antigen presentation.

NK cells patrol the bloodstream, lymph, and connective tissues conducting immunological surveillance. They detect and destroy virally infected host cells and malignant (cancerous) cells through the "missing self" hypothesis:

• Normal, healthy nucleated host cells express high surface levels of Class I Major Histocompatibility Complex (MHC-I) molecules. When an NK cell interrogates a normal cell, its killer-inhibitory receptors (KIRs) bind Class I MHC, delivering a dominant inhibitory signal that prevents cell lysis.
• Many viruses (such as cytomegalovirus) and malignant transformations evade cytotoxic T-cells by down-regulating or completely silencing Class I MHC expression. When an NK cell encounters a host cell lacking Class I MHC, its inhibitory receptors remain unbound. The NK cell's activating receptors dominate, triggering targeted cytotoxic degranulation:
  1. The NK cell releases perforins, which bind to the target cell membrane and polymerize in the presence of calcium to form cylindrical transmembrane pores.
  2. The NK cell releases granzymes (serine proteases), which pass through the perforin pores into the target cell cytoplasm.
  3. Granzymes cleave intracellular procaspases, triggering caspase cascades that execute apoptosis (programmed cell death). Apoptosis shrivels the target cell and destroys its internal viral DNA without releasing infectious virions into extracellular fluid.

---

Antimicrobial Proteins: Interferons and the Complement Cascade

Antimicrobial proteins enhance innate defenses by attacking pathogens directly or impeding their reproductive capabilities.

Interferons (IFNs): Cytokine Antiviral Defense

Interferons are small cytokine signaling proteins (primarily interferon-alpha [IFN-$\alpha$], interferon-beta [IFN-$\beta$], and interferon-gamma [IFN-$\gamma$]) secreted by host cells infected with viruses. Interferons do not protect the already infected host cell; rather, they serve as a paracrine warning system:

1. A host cell invaded by a virus transcribes interferon genes and secretes IFN molecules into the interstitial fluid before the host cell dies.
2. Interferons diffuse to neighboring uninfected cells and bind specific cell-surface interferon receptors.
3. Receptor binding induces uninfected cells to synthesize latent antiviral proteins (AVPs), such as protein kinase R (PKR) and 2',5'-oligoadenylate synthetase.
4. If a virus subsequently penetrates the warned cell, these AVPs activate, degrading viral messenger RNA and phosphorylating elongation factors to halt all ribosomal protein synthesis, arresting viral replication.
5. In addition to antiviral action, IFN-$\alpha$ and IFN-$\beta$ activate natural killer cells, while IFN-$\gamma$ (secreted primarily by activated T-cells and NK cells) acts as the most potent physiological activator of macrophages.

The Complement System: Pathways and Effector Outcomes

The complement system comprises a cascade of more than 30 soluble plasma proteins and membrane-bound regulators (designated C1 through C9, Factor B, Factor D, etc.) synthesized predominantly by hepatocytes. Complement proteins circulate in the blood and tissue fluids as inactive zymogens (proenzymes). Once triggered, the cascade proceeds through a tightly regulated sequential proteolytic amplification, where each active enzyme cleaves and activates multiple downstream precursors.

   Classical Pathway                Lectin Pathway               Alternative Pathway
(Antigen-Antibody Complexes)     (Mannose-Binding Lectin)     (Spontaneous C3 Hydrolysis)
             │                              │                              │
             └──────────────────────┬───────┴──────────────────────────────┘
                                    ▼
                             C3 Convertase
                                    │
                                    ▼
                             C3 Cleavage
                                    │
                     ┌──────────────┴──────────────┐
                     ▼                             ▼
                    C3a                           C3b
                     │                             │
                     ▼                             ├────────────────────────┐
               Inflammation                        ▼                        ▼
            (Histamine Release &              Opsonization            C5 Convertase
            Neutrophil Chemotaxis)         (Enhanced Phagocytosis)          │
                                                                            ▼
                                                                       C5 Cleavage
                                                                            │
                                                             ┌──────────────┴──────────────┐
                                                             ▼                             ▼
                                                            C5a                           C5b
                                                             │                             │
                                                             ▼                             ▼
                                                       Inflammation                 Recruits C6, C7, C8
                                                    (Chemotaxis & Vessel            + Polymerizes C9
                                                        Permeability)                      │
                                                                                           ▼
                                                                                Membrane Attack Complex
                                                                                         (MAC)
                                                                                           │
                                                                                           ▼
                                                                                   Target Cell Lysis

The cascade is initiated through three distinct upstream pathways, all of which converge on the formation of a C3 convertase enzyme that cleaves C3 into C3a and C3b:

1. The Classical Pathway: Initiated when antibodies (IgG or IgM) bind to specific foreign antigens on a pathogen surface. The C1 complement complex binds to the exposed constant (Fc) regions of the antigen-antibody complex, triggering downstream cleavage of C4 and C2 to form the classical C3 convertase (C4b2a).
2. The Lectin Pathway: Initiated when host plasma proteins called mannose-binding lectins (MBLs) recognize and bind specific mannose or carbohydrate residues on microbial surface glycoproteins and lipopolysaccharides. This activates MBL-associated serine proteases (MASPs) that cleave C4 and C2, converging on the same C3 convertase as the classical pathway.
3. The Alternative Pathway: Initiated independently of antibodies or lectins through spontaneous, low-level hydrolytic activation ("tick-over") of C3 in plasma, forming C3(H2O). If this activated fragment contacts a microbial cell wall lacking host surface regulatory proteins (such as sialic acid, decay-accelerating factor, or Factor H), Factor B and Factor D bind to form the alternative C3 convertase (C3bBb), which rapidly amplifies via positive feedback.

Effector Outcomes of Complement Activation

Regardless of the activation pathway, complement execution yields three life-saving outcomes:

• Opsonization (Mediated by C3b): Cleaved C3b fragments covalently bond to the outer surface of bacteria, viruses, and immune complexes. Macrophages and neutrophils express complement receptor 1 (CR1) that binds C3b with high affinity, transforming slippery or encapsulated bacteria into easily phagocytized targets.
• Inflammatory Amplification (Mediated by C3a and C5a): Fragments C3a and C5a function as potent anaphylatoxins. They bind to G-protein-coupled receptors on tissue mast cells and circulating basophils, triggering immediate degranulation and the release of histamine and serotonin. This increases microvascular permeability and vasodilation. Furthermore, C5a acts as an exceptionally powerful chemoattractant that guides neutrophils and monocytes toward the site of active complement fixation.
• Lysis via the Membrane Attack Complex (MAC; Mediated by C5b-C9): C3b also associates with C3 convertase to form C5 convertase, which cleaves C5 into C5a and C5b. Surface-bound C5b recruits C6 and C7, forming a stable hydrophobic complex that inserts into the pathogen's outer lipid bilayer. This complex then binds C8, which penetrates deeper into the membrane. Finally, this C5b-C8 assembly coordinates the binding and circular polymerization of 10 to 18 molecules of C9, constructing a large (10 nm wide) transmembrane cylindrical pore termed the Membrane Attack Complex (MAC). The MAC creates an unregulated channel through which extracellular water, sodium, and calcium ions rush uncontrollably into the hypertonic microbial interior, overwhelming the cell's osmotic resilience and causing rapid osmotic cytolysis.

---

The Inflammatory Response: Vascular and Cellular Dynamics

Inflammation is a non-specific, localized protective response of vascularized tissue to injury, physical trauma, intense heat, chemical irritation, or infection. The fundamental goals of the inflammatory response are to inactivate or destroy the offending agent, prevent the spread of injurious factors to adjacent tissues, clear necrotic cellular debris, and initiate tissue repair.

The Cardinal Signs of Acute Inflammation

In the first century AD, the Roman physician Celsus documented the four classical cardinal signs of acute inflammation, to which the 19th-century pathologist Rudolf Virchow added the fifth:

1. Rubor (Redness): Caused by local arteriolar vasodilation producing active hyperemia (increased blood flow into the injured tissue bed).
2. Calor (Heat): Caused by the influx of warm, core body blood traveling through dilated superficial microvessels, accompanied by increased local metabolic activity.
3. Tumor (Swelling / Edema): Caused by increased capillary and venular permeability, permitting protein-rich fluid (exudate) to leave the vascular space and accumulate in the interstitial compartment.
4. Dolor (Pain): Caused by mechanical pressure exerted by accumulating interstitial edema fluid against local sensory nerve endings, coupled with the direct chemical sensitization of nociceptors by inflammatory mediators (primarily bradykinin and prostaglandins).
5. Functio Laesa (Loss of Function): Added by Virchow to reflect temporary or permanent disability of the inflamed structure resulting from mechanical swelling, joint stiffness, or severe pain.

Chemical Mediators of the Inflammatory Response

Tissue trauma and pathogen entry trigger the immediate discharge of biochemical signaling molecules from resident cells, damaged tissues, and circulating plasma cascades:

• Histamine: Stored in preformed granules within tissue mast cells and circulating basophils. Released immediately in response to mechanical trauma, complement fragments (C3a, C5a), or IgE cross-linking. Histamine acts on H1 endothelial receptors, causing rapid arteriolar vasodilation and opening endothelial intercellular gaps in post-capillary venules.
• Kinins (Bradykinin): Cleaved from plasma kininogens by the enzyme kallikrein following contact with exposed subendothelial collagen. Bradykinin induces profound vasodilation, increases microvascular permeability, and directly stimulates type C nociceptive nerve fibers to produce sharp, throbbing pain.
• Prostaglandins (PGE2, PGI2): Synthesized from arachidonic acid via the cyclooxygenase (COX-1 and COX-2) enzymatic pathways in damaged cells, platelets, and leukocytes. Prostaglandins potently amplify vascular permeability, induce vasodilation, sensitize pain receptors to bradykinin, and act on the hypothalamic thermostat to induce fever.
• Leukotrienes: Synthesized from arachidonic acid via the 5-lipoxygenase pathway. Leukotrienes cause sustained microvascular permeability and act as powerful chemotactic agents for neutrophils.
• Cytokines (Tumor Necrosis Factor-Alpha [TNF-$\alpha$] and Interleukin-1 [IL-1]): Synthesized and secreted by activated macrophages and dendritic cells. They stimulate endothelial cells to express cell adhesion molecules, induce systemic acute-phase protein synthesis in the liver, and reset the hypothalamic setpoint to generate fever.

Four Stages of Phagocyte Mobilization

Within minutes of acute tissue injury, phagocytic leukocytes—initially neutrophils, followed hours later by monocytes—are recruited from the bloodstream into the injured connective tissue through an orderly four-step sequence:

1. Leukocytosis: Inflammatory cytokines (IL-1 and TNF-$\alpha$) circulating from the injury site stimulate the red bone marrow to release stored neutrophils into the bloodstream. Within a few hours, the circulating neutrophil count can increase three- to five-fold (neutrophilic leukocytosis).
2. Margination (Pavementing): Inflammatory cytokines induce capillary endothelial cells near the injury site to express surface adhesion proteins called selectins. Circulating neutrophils express complementary carbohydrate ligands that loosely bind these selectins. The neutrophils slow down, leave the central high-velocity axial bloodstream, and roll along the endothelial surface. As they roll, stronger adhesion molecules called integrins on the neutrophils bind firmly to intercellular adhesion molecules (ICAMs) on the endothelial cells, anchoring the leukocytes securely to the vessel wall.
3. Diapedesis (Extravasation): Anchored neutrophils flatten dramatically and extend pseudopods between adjacent endothelial cells. Assisted by platelet-endothelial cell adhesion molecules (PECAM-1), the neutrophils actively squeeze through the widened intercellular junctions of post-capillary venules into the interstitial fluid without rupturing the vessel wall.
4. Chemotaxis: Once in the interstitial space, neutrophils follow a positive concentration gradient of chemotactic factors (C5a, leukotriene B4, bacterial peptides) toward the precise focus of tissue damage, where they begin immediate phagocytosis.

Monocytes follow this exact same migratory sequence, but arrive 8 to 12 hours later. Upon exiting the bloodstream and entering the connective tissue, monocytes undergo cellular differentiation, swelling and synthesizing massive numbers of lysosomes to transform into voracious macrophages. These macrophages replace the dying neutrophils, phagocytize cellular debris, clear pus, and coordinate subsequent tissue repair by secreting growth factors (TGF-$\beta$, VEGF, FGF).

---

Systemic Innate Defenses: The Physiology of Fever (Pyrexia)

While inflammation is an adaptive localized response, fever (pyrexia) represents an adaptive systemic response of the entire organism to infection, extensive trauma, or inflammatory illness.

Neurochemical Regulation of the Hypothalamic Setpoint

Core body temperature is tightly controlled by the thermoregulatory center in the preoptic area of the anterior hypothalamus, which maintains a standard baseline setpoint of approximately 37.0°C (98.6°F). Fever occurs when this hypothalamic setpoint is actively reset upward:

1. Phagocytic leukocytes and macrophages engulfing bacteria or exposed to endotoxins release chemical signaling proteins called endogenous pyrogens (predominantly interleukin-1 [IL-1], tumor necrosis factor-alpha [TNF-$\alpha$], and interleukin-6 [IL-6]).
2. Endogenous pyrogens travel via the bloodstream to the brain and act on the organum vasculosum of the lamina terminalis (OVLT), a specialized sensory circumventricular organ lacking a blood-brain barrier.
3. Endothelial cells within the OVLT synthesize and release prostaglandin E2 (PGE2) into hypothalamic tissue via the cyclooxygenase-2 (COX-2) enzyme.
4. Binding of PGE2 to EP3 receptors on thermosensitive neurons in the anterior hypothalamus triggers an upward shift in the homeostatic temperature setpoint (for example, from 37.0°C to 39.0°C [102.2°F]).

Microbial Infection / Endotoxin Exposure
        │
        ▼
Activated Macrophages & Neutrophils
        │
        ▼
Release of Endogenous Pyrogens (IL-1, TNF-α, IL-6)
        │
        ▼
Circulate to Hypothalamus (OVLT)
        │
        ▼
Induction of Cyclooxygenase-2 (COX-2) & Prostaglandin E2 (PGE2)
        │
        ▼
Hypothalamic Thermostat Setpoint Reset Upward (e.g., 39.0°C)
        │
        ├─────────────────────────────────────────────────┐
        ▼                                                 ▼
Heat-Gain Mechanisms Activated:                   Adaptive Physiological Benefits:
- Cutaneous Vasoconstriction (Chills/Pale Skin)    - Accelerated Enzymatic & Metabolic Rates
- Involuntary Shivering (Shivering Thermogenesis) - Enhanced Interferon & Phagocytic Efficacy
- Behavioral Heat Retention (Seeking Warmth)       - Hepatic/Splenic Sequestration of Iron & Zinc

The Chill Phase, Plateau, and Defervescence (Crisis)

• The Chill Phase: When the hypothalamic thermostat is newly reset to 39.0°C, the current core body temperature (37.0°C) is perceived by the brain as cold. The hypothalamus triggers heat-promoting reflexes: cutaneous vasoconstriction shunts blood away from the skin to conserve heat (causing the patient's skin to feel cold and appear pale), while skeletal muscle contractions induce involuntary shivering (shivering thermogenesis). The patient experiences severe chills and piles on blankets.
• Plateau Phase: Core temperature rises until it reaches the new 39.0°C setpoint. The chills subside, and the skin feels hot and dry.
• Defervescence (Crisis Phase): As the infection is cleared and pyrogen levels decline, the hypothalamic setpoint resets back down to the normal 37.0°C. The hypothalamus now perceives the 39.0°C body temperature as excessively hot, triggering heat-loss mechanisms: intense cutaneous vasodilation (flushed skin) and profuse sweating (diaphoresis). The fever "breaks."

Adaptive Benefits of Moderate Fever

Moderate fever is not a pathological defect, but an evolutionary conserved protective defense:

• Nutrient Sequestration: Elevated core temperatures prompt the liver and spleen to sequester iron and zinc, two micronutrients that invading bacteria require in large amounts to replicate their DNA and divide.
• Accelerated Metabolic Rate: According to the van 't Hoff temperature coefficient ($Q_{10}$), every 1°C elevation in body temperature increases tissue metabolic rate by approximately 10% to 13%. This accelerates phagocytic activity, speeds up antibody synthesis, and promotes faster cellular repair.
• Enhanced Immune Efficacy: Elevated temperatures boost the biological activity and antiviral potency of interferons, enhance T-lymphocyte proliferation, and inhibit the growth of certain temperature-sensitive pathogens.

Clinical Pharmacology: Mechanism of Antipyretics

Common antipyretic medications—such as acetaminophen (paracetamol) and nonsteroidal anti-inflammatory drugs (NSAIDs, including ibuprofen, naproxen, and aspirin)—do not shut down the immune response or alter peripheral heat dissipation directly. Instead, they act pharmacologically by inhibiting the cyclooxygenase (COX) enzymes (COX-1 and COX-2). By blocking the enzymatic conversion of arachidonic acid into prostaglandin E2 (PGE2) within the hypothalamus, antipyretics restore the hypothalamic setpoint to 37.0°C, inducing rapid vasodilation and sweating that return body temperature to normal.